Exagen (XGN) Income from Continuing Operations (2018 - 2026)
Exagen (XGN) posted Income from Continuing Operations of 3967000.0 for Q1 2026, up 15.11% quarter-over-quarter from 4673000.0 in Q4 2025, and down 5.73% year-on-year from 4208137.97 in Q1 2025.
Exagen (XGN) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Exagen (XGN) has reported Income from Continuing Operations for 9 consecutive years, with 3967000.0 the latest figure, recorded in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 3967000.0, down 5.73% year-over-year; the trailing twelve-month figure through Mar 2026 was 20166000.0 (down 30.04% YoY), and the FY2025 annual result was 19951000.0, down 31.99% from the prior year.
- Income from Continuing Operations was 3967000.0 for Q1 2026 at Exagen, up from 4673000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 2966000.0 in Q2 2024 and troughed at 15117000.0 in Q4 2022.
- Average Income from Continuing Operations over 5 years is 6540176.47, with a median of 5028000.0 recorded in 2024.
- Year-over-year, Income from Continuing Operations tumbled 128.86% in 2022 and jumped 65.83% in 2023.
- Over 5 years, Income from Continuing Operations stood at 15117000.0 in 2022, then surged by 63.35% to 5540000.0 in 2023, then jumped by 32.11% to 3761000.0 in 2024, then dropped by 24.25% to 4673000.0 in 2025, then rose by 15.11% to 3967000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 3967000.0 in Q1 2026, 4673000.0 in Q4 2025, and 7087000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Exagen | 112.36 Mn | 90.84 Mn | 10.21 Mn | -3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.97 Mn |
| Dec 31, 2025 | -4.67 Mn |
| Sep 30, 2025 | -7.09 Mn |
| Jun 30, 2025 | -4.44 Mn |
| Mar 31, 2025 | -3.75 Mn |
| Dec 31, 2024 | -3.76 Mn |
| Sep 30, 2024 | -5.03 Mn |
| Jun 30, 2024 | -2.97 Mn |
| Mar 31, 2024 | -3.36 Mn |
| Dec 31, 2023 | -5.54 Mn |
| Sep 30, 2023 | -5.42 Mn |
| Jun 30, 2023 | -5.01 Mn |
| Mar 31, 2023 | -7.69 Mn |
| Dec 31, 2022 | -15.12 Mn |
| Sep 30, 2022 | -8.44 Mn |
| Jun 30, 2022 | -14.67 Mn |
| Mar 31, 2022 | -10.27 Mn |
| Dec 31, 2021 | -7.05 Mn |
| Sep 30, 2021 | -7.18 Mn |
| Jun 30, 2021 | -6.41 Mn |